MedPath

Tolerance to Light for Patients Suffering From Keratitis

Not Applicable
Completed
Conditions
Keratitis
Registration Number
NCT03586505
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

In order to develop an innovative device to study infectious keratitis, we need to illuminate the cornea of patients suffering from an infectious keratitis with red or near-infrared light. Because of technical reasons the shortest possible wavelength (red) presents advantages.

Detailed Description

The aim of this preliminary study is to measure the maximal intensity tolerated during illumination with 6 wavelength corresponding : 2 red, 2 far red and 1 near infrared lights in order to determine the shortest wavelength well tolerated by patients, in comparison with the standard blue light illumination.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Social security insurance
  • Suspected infectious keratitis (clinically defined. No lab testing required)
  • Signed informed consent
Exclusion Criteria
  • Major Blepharospasm
  • Aphakia (absence of lens)
  • Pregnant woman
  • Nursing mother

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Light intensityAt the inclusion

For each wavelength, the highest light intensity tolerated by the patient is measured (mWatts/cm² )

Secondary Outcome Measures
NameTimeMethod
Severity of the keratitisAt the inclusion

It is determined by slit lamp. The result is "severe" or "not severe"

Trial Locations

Locations (1)

CHU de Saint-Etienne

🇫🇷

Saint-Étienne, France

CHU de Saint-Etienne
🇫🇷Saint-Étienne, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.